1. 1. Bahador M, Larizadeh MH, Samareh Fekri M, Naghibzadeh-Tahami A, Mohseni M, Arabnejad F (2022) Investigation of pulmonary complications induced by radiotherapy and chemotherapy in patients with breast cancer through spirometry, CT scan imaging patterns, and clinical criteria in a six-month follow-up. Middle East Journal of Cancer, 13(4): 692-700.
2. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram‐Baptiste D, Saslow D, et al. (2018) Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians, 68(4): 297-316. [
DOI:10.3322/caac.21446]
3. Lee B, Lee S, Sung J, Yoon M (2014) Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT. J Radiol Prot, 34(2): 325-31. [
DOI:10.1088/0952-4746/34/2/325]
4. Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, et al. (2008) Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer, 112(6): 1371-9. [
DOI:10.1002/cncr.23307]
5. Wu AK, Damico NJ, Healy E, Kharouta MZ, Khandel G, Deshane A, et al. (2021) Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Tech Innov Patient Support Radiat Oncol, 20: 28-34. [
DOI:10.1016/j.tipsro.2021.10.003]
6. Kikawa Y, Kosaka Y, Hashimoto K, Hohokabe E, Takebe S, Narukami R, et al. (2017) Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre survey. ESMO Open, 2(1): e000161. [
DOI:10.1136/esmoopen-2017-000161]
7. Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, et al. (2009) Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample. Int J Radiat Oncol Biol Phys, 75(3): 764-70. [
DOI:10.1016/j.ijrobp.2008.11.037]
8. NSABP B-39, RTOG 0413 (2006): A Randomized Phase III Study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol, 4(10):719-21.
9. Farhood B, Bahreyni Toossi MT, Vosoughi H, Khademi S, Knaup C (2016) Measurement of thyroid dose by TLD arising from radiotherapy of breast cancer patients from supraclavicular field. J Biomed Phys Eng, 6(3):147-56.
10. Vlachopoulou V, Malatara G, Delis H, Kardamakis D, Panayiotakis G (2013) Estimation of the risk of secondary cancer in the thyroid gland and the breast outside the treated volume in patients undergoing brain, mediastinum and breast radiotherapy. Radiat Prot Dosimetry, 154(1): 121-6. [
DOI:10.1093/rpd/ncs134]
11. Momeni Z, Tavakoli MB, Atarod M (2018) Estimation of the thyroid secondary cancer risk on the patient of standard breast external beam radiotherapy. J Med Signals Sens, 8(4): 238-43. [
DOI:10.4103/jmss.JMSS_12_18]
12. Ron E and Brenner A (2010) Non-malignant thyroid diseases after a wide range of radiation exposures. Radiat Res, 174(6): 877-88. [
DOI:10.1667/RR1953.1]
13. Gul A, Faaruq S, Abbasi NZ, Siddique T, Ali A, Shehzadi NN, et al. (2013) Estimation of absorbed dose to thyroid in patients treated with radiotherapy for various cancers. Radiat Prot Dosimetry, 156(1): 37-41. [
DOI:10.1093/rpd/nct043]
14. Nejad SS, Bahador M, Yazdani S, Kiani M (2023) Comparative evaluation of wedge and field-in-field methods in minimizing brachial plexus radiation dose in breast cancer patients undergoing radiotherapy. Frontiers in Biomedical Technologies, 12(2): 446-450.
15. Wolny-Rokicka E, Tukiendorf A, Wydmański J, Roszkowska D, Staniul B, Zembroń-Łacny A (2016) Thyroid function after postoperative radiation therapy in patients with breast cancer. Asian Pacific journal of cancer prevention: APJCP, 17(10): 4577.
16. Vlachopoulou V, Malatara G, Delis H, Kardamakis D, Panayiotakis G (2013) Estimation of the risk of secondary cancer in the thyroid gland and the breast outside the treated volume in patients undergoing brain, mediastinum and breast radiotherapy. Radiation Protection Dosimetry, 154(1): 121-6. [
DOI:10.1093/rpd/ncs134]
17. Singh S, Verma A, Aryal G, Thapa S, Khakurel S, Shrestha K (2016) Thyroid hormone profile in patients with chronic kidney disease: a single centre study. J Nepal Health Res Counc, 14(34): 197-201.
18. Daoud J, Siala W, Guermazi F, Besbes M, Frikha M, Ghorbel M, et al. (2005) Hypothyroidism following cervical irradiation in the management of carcinoma of the nasopharynx and of the breast: a prospective study on eighty-four cases. Cancer Radiother, 9(3): 140-7. [
DOI:10.1016/j.canrad.2005.03.002]
19. Ansari L, Nasiri N, Aminolroayaei F, Sani KG, Dorri-Giv M, Abedi-Firouzjah R, et al. (2020) The measurement of thyroid absorbed dose by Gafchromic™ EBT2 film and changes in thyroid hormone levels following radiotherapy in patients with breast cancer. J Med Signals Sens, 10(1): 42-7. [
DOI:10.4103/jmss.JMSS_10_19]
20. Tunio MA, Al Asiri M, Bayoumi Y, Stanciu LG, Al Johani N, Al Saeed EF (2015) Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study. J Cancer Res Ther, 11(4): 684-9. [
DOI:10.4103/0973-1482.167613]
21. Nageeti T, Mahfouz M, Al Gaod M, Zatar R (2018) Absorbed radiation dose in the thyroid gland following regional nodal irradiation for breast cancer. Int J Oncol Res, 1(2). [
DOI:10.23937/ijor-2017/1710010]
